Reaction Details |
| Report a problem with these data |
Target | Peroxisome proliferator-activated receptor delta |
---|
Ligand | BDBM50099491 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEBML_153613 |
---|
EC50 | 6200±n/a nM |
---|
Citation | Brown, PJ; Stuart, LW; Hurley, KP; Lewis, MC; Winegar, DA; Wilson, JG; Wilkison, WO; Ittoop, OR; Willson, TM Identification of a subtype selective human PPARalpha agonist through parallel-array synthesis. Bioorg Med Chem Lett11:1225-7 (2001) [PubMed] |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Peroxisome proliferator-activated receptor delta |
---|
Name: | Peroxisome proliferator-activated receptor delta |
Synonyms: | NR1C2 | NUC1 | NUCI | Nuclear hormone receptor 1 | Nuclear receptor subfamily 1 group C member 2 | PPAR delta | PPAR-beta | PPARB | PPARD | PPARD_HUMAN | Peroxisome proliferator-activated receptor | Peroxisome proliferator-activated receptor beta | Peroxisome proliferator-activated receptor delta |
Type: | Enzyme |
Mol. Mass.: | 49910.45 |
Organism: | Homo sapiens (Human) |
Description: | Q03181 |
Residue: | 441 |
Sequence: | MEQPQEEAPEVREEEEKEEVAEAEGAPELNGGPQHALPSSSYTDLSRSSSPPSLLDQLQM
GCDGASCGSLNMECRVCGDKASGFHYGVHACEGCKGFFRRTIRMKLEYEKCERSCKIQKK
NRNKCQYCRFQKCLALGMSHNAIRFGRMPEAEKRKLVAGLTANEGSQYNPQVADLKAFSK
HIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKE
ISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNK
DGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGD
RPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRI
KKTETETSLHPLLQEIYKDMY
|
|
|
BDBM50099491 |
---|
n/a |
---|
Name | BDBM50099491 |
Synonyms: | 2-(4-(2-(3-cyclohexyl-1-(4-cyclohexylbutyl)ureido)ethyl)phenylthio)-2-methylpropanoic acid | 2-(4-{2-[3-Cyclohexyl-1-(4-cyclohexyl-butyl)-ureido]-ethyl}-phenylsulfanyl)-2-methyl-propionic acid | CHEMBL21241 | GW7647 | cid_3392731 |
Type | Small organic molecule |
Emp. Form. | C29H46N2O3S |
Mol. Mass. | 502.752 |
SMILES | CC(C)(Sc1ccc(CCN(CCCCC2CCCCC2)C(=O)NC2CCCCC2)cc1)C(O)=O |
Structure |
|